DNp73 improves generation efficiency of human induced pluripotent stem cells

BMC Cell Biology

Volumn 13, Issue , 2012, Pages

  Lin, Yi ^a   Cheng, Zuxin ^a   Yang, Zhijian ^a   Zheng, Jingui ^a   Lin, Tongxiang ^a  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL RENEWAL; CONTROLLED STUDY; DNP73 GENE; EMBRYO; FIBROBLAST; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; CYTOLOGY; GENE DELETION; GENETICS; METABOLISM;

IPS;

CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 84862808326     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-13-9     Document Type: Article

References (24)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
3. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
4. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Wahl GM, Belmonte JC. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
5. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009, 460:1145-1148.
6. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, Blasco MA, Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
7. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
8. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005, 7:165-171.
9. Xu Y. A new role for p53 in maintaining genetic stability in embryonic stem cells. Cell Cycle 2005, 4(3):363-4.
10. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113(5):631-42.
11. Melino G, De Laurenzi V, Vousden KH. p73: friend or foe in tumorigenesis. Nat Rev Cancer 2002, 2:605-615.
12. Melino G, Lu X, Gasco M, Crook T, Knight RA. Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 2003, 28:663-670.
13. Grob TJ, Novak U, Maisse C, Barcaroli D, Lüthi AU, Pirnia F, Hügli B, Graber HU, De Laurenzi V, Fey MF, Melino G, Tobler A. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001, 8(12):1213-23.
14. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113(5):643-55.
15. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38:431-440.
16. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
17. Theunissen TW, Silva JC. Switching on pluripotency: a perspective on the biological requirement of Nanog. Philos Trans R Soc Lond B Biol Sci 2011, 366(1575):2222-9.
18. Grad I, Hibaoui Y, Jaconi M, Chicha L, Bergström-Tengzelius R, Sailani MR, Pelte. NANOG priming before full reprogramming may generate germ cell tumours. Eur Cell Mater 2011, 22:258-74.
19. Moon JH, Kwon S, Jun EK, Kim A, Whang KY, Kim H, Oh S, Yoon BS, You S. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun 2011, 412(1):175-81. Epub 2011 Jul 23.
20. Han JW, Yoon YS. Epigenetic landscape of pluripotent stem cells. Antioxid Redox Signal 2012, doi:10.1089/ars.2011.4375.
21. Patterson M, Chan DN, Ha I, Case D, Cui Y, Handel BV, Mikkola HK, Lowry WE. Defining the nature of human pluripotent stem cell progeny. Cell Res 2012, 22(1):178-93.
22. Uri Ben-David & Nissim Benvenisty The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011, 11:268-277. Uri Ben-David & Nissim Benvenisty.
23. Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S. A chemical platform for improved induction of human iPSCs. Nat Methods 2009, 6:805-808.
24. Krizhanovsky V, Lowe SW. Stem cells: the promises and perils of p53. Nature 2009, 460:1085-1086.